Numbers

The Numbers

Oriana's financials read like two companies stitched together. The income statement is a pure Indian renewables growth story — revenue compounded from ₹21 crore in FY2020 to ₹987 crore in FY2025 (roughly 117% CAGR) and EBITDA margin has tripled from 9.5% to 24.9%. The balance sheet and working-capital tells a very different story — debtor days almost doubled to 146 in FY2025, working-capital days jumped from 10 to 81, and free cash flow has been structurally negative in every year except one. At ₹2,189 (17 Apr 2026), the stock trades at roughly 19x TTM earnings and 13x EV/EBITDA after a 27% drawdown from the October 2025 high of ₹3,001. The single metric that rerates or derates this stock from here is debtor days. Everything else — BESS mix, asset-recycling cadence, order book — is secondary.

1. Snapshot

The snapshot captures the tension. Scale, profitability, and returns on capital all look exceptional for a micro-cap contractor; receivables discipline does not. The company built a ₹4,365 crore market capitalisation on trust that the working-capital spike is temporary. That trust is the whole investment.

2. Revenue and earnings power — six-year view

Oriana's revenue step-function is the cleanest chart in the file. It broke out of contractor-scale in FY2024, then doubled again in FY2025, with margins expanding through both years — the opposite of what normally happens when EPC players chase volume.

The margin line is the more important of the two. A pure contractor should see margin compression as revenue scales six-fold in two years — logistics, procurement, subcontractor costs all bid up. Oriana did the opposite. The only credible explanation is mix shift: higher-margin IPP development and BESS revenue (with fatter per-MW economics than rooftop EPC) pushed the blended margin up while EPC volumes scaled. This is the mix-shift thesis working in real time. If it reverses — if FY2026 margin prints below 22% — the multiple has to come down.

3. Quarterly cadence — the last two half-years

Oriana reports on a half-yearly cadence (SME to Main Board transition). The last three half-yearly prints show the acceleration rather than a seasonal pattern.

H1 FY2026 (the Sep-2025 half) delivered ₹781 crore of revenue — a ~120% jump versus H1 FY2025 — with operating margin holding at 23%. The quarterly print confirms the FY2025 full-year trend is continuing rather than reflecting one-off asset sales or pull-forward.

4. Cash generation — are the earnings real?

This is the chart that matters most after the revenue chart, and it is the most uncomfortable one.

Operating cash flow finally caught up with reported profit in FY2025 (CFO of ₹290 crore versus ₹159 crore of net income), which is encouraging. But free cash flow — CFO plus investing activity — has been deeply negative every year, including ₹232 crore of negative free cash in FY2025 because the company invested ₹522 crore in IPP build-out and working capital. That is the capital-recycling model showing up in the cash flow statement. The thesis is that this investing outflow is temporary — the owned assets get sold to funds (Actis bought ~238 MW for around USD 108M in FY2025) and the equity recycles. The counterfactual is that the cash outflow is structural, funded indefinitely by debt and equity raises.

5. Working capital — the canary

This is the single chart that most determines whether Oriana works.

Debtor days and working-capital days moved in lockstep from FY2024 to FY2025, and the working-capital figure jumped by seven-fold. On ₹987 crore of FY2025 revenue, that 71-day move represents roughly ₹190 crore of extra cash stuck in the cycle. FY2021's debtor-day spike to 148 was on a smaller base and was absorbed by equity raises; at today's scale, the same pattern has much larger absolute cash consequences. The FY2026 annual report needs a coherent narrative and visible progress back below 100 days, or the receivables-concentration risk becomes a balance-sheet risk.

6. Balance sheet and leverage

One surprising positive: leverage has fallen even as the business has scaled. The FY2024 IPO/placement brought equity in faster than borrowings grew.

Debt-to-equity collapsed from 4.0x in FY2020 to 0.53x in FY2025 because reserves grew from ₹1 crore to ₹489 crore on the back of retained earnings plus a QIP in FY2025. Debt-to-EBITDA of 1.1x is the lowest in the peer set. This matters because it is the operational cushion that lets Oriana absorb a working-capital shock without emergency refinancing. Borrowings crept back to ₹316 crore at H1 FY2026 end — watch that climb. If D/E drifts back above 1.0x without a matching Actis-type monetisation, the balance sheet is financing growth rather than selling it.

7. Valuation — now vs where it has been

Oriana has only been listed since August 2023, so there is no twenty-year multiple history to anchor against. The price chart is the best available proxy for how the market's view has evolved.

The stock traded at roughly ₹340 at IPO, ran to ₹2,474 by June 2024 (a 7x in ten months), corrected 47% to ₹1,310 by February 2025 as SME broad-market sentiment soured, then re-rated to an all-time high of ₹3,001 in October 2025 as FY2025 results landed and the Actis deal was announced. The current ₹2,189 is 27% below that October high and 18% above the one-year low. Put simply, the market has already lived through one cycle of fear and greed on this name — and the current level is roughly the 18-month mean.

At 18.8x TTM earnings and 13.2x TTM EV/EBITDA, Oriana is trading materially below the headline peer-set median (Adani Green 113x P/E, Premier Energies 35x, Waaree 29x) and only slightly above KPI Green (21x). That is the right comparison — a growth-stage Indian renewables IPP with actual cash-backed ROCE, not a pure-module manufacturer or a utility-scale IPP. On that comparison, the multiple looks fair to modest.

8. Peer comparison

Five Indian renewables peers, one row per company, native currency.

Oriana sits in the bottom-right quadrant — highest ROCE in the set at 42%, lowest P/E outside of KPI Green. Either (i) the market is right that working-capital risk and micro-cap liquidity justify the discount, or (ii) the mix is wrong because Oriana's reported ROCE is pre-IPP scale-up and will mean-revert toward Adani Green's 8.7% as the balance-sheet accumulates unsold IPP assets. The Actis-style monetisation cadence is the variable that decides which explanation wins.

9. Capital allocation

Oriana has not paid dividends or bought back stock. Every rupee of cash has gone to capex and working-capital expansion, with equity issuance (the NSE SME IPO in August 2023 followed by the FY2025 QIP) providing the cushion.

The bars say everything. CFI (investing) outflows track CFF (financing) inflows almost exactly every year. Oriana is a growth-stage company that raises money from debt-plus-equity and deploys it into IPP assets plus working capital. The capital-allocation test is whether CFO catches up with CFI as the Actis-style recyclings materialise. FY2025 is the first year CFO even approached half of CFI. FY2026 needs to see CFO match or exceed CFI without needing a capital raise.

10. Fair-value range

With only three years of public financials, a DCF is more fiction than forecast. A multiples-based range anchored on the peer set and forward earnings is more honest.

The bear outcome at ₹1,400 is roughly where the stock bottomed in February 2026; the bull at ₹3,200 is above the all-time high. Today's ₹2,189 sits within 1% of the base case, which is a reasonable description of where the market has arrived: the thesis is plausible but unproven, and the discount or premium from here is set by two hard data points — debtor days and the next asset-recycling deal.

11. What the numbers confirm, contradict, and what to watch

The numbers confirm that the economic engine is real — 117% revenue CAGR with expanding margin is not something a failing contractor produces, and Oriana earns the sector's best ROCE with the lowest leverage, while the Actis transaction validates the asset-recycling model at institutional-grade valuations. The numbers contradict the tidier narrative that this is a clean-growth story: FY2024's ₹2 crore CFO against ₹54 crore of net income and FY2025's 71-day jump in working-capital days both say earnings quality is contingent on specific monetisation events, not on steady-state EPC profitability. What to watch in the next twelve months is three things, in order: FY2026 debtor days (needs to normalise to 100–110), a second Actis-style asset sale at roughly USD 0.45M per MW or better, and the BESS + green molecule share of revenue — anything less than mid-teens keeps the multiple capped at the current EPC-plus-optionality level.